United States v. Roche, DevonUnited States v. Roche, Devon
EASTERBROOK, Circuit Judge. Devon Roche sold ecstasy to Derrick Perkins three times during the summer of 2000. Before each sale, Roche called Perkins to discuss logistics. That is, Roche thrice used a telecommunications device to facilitate the distribution of a controlled substance, in violation of
As part of the deal, Roche agreed to a limited waiver of his right to appeal:
I agree that the Court has jurisdiction and authority to impose any sentence within the statutory maximum set for my offense as set forth above in paragraph 9.c. of this plea agreement. With that understanding, I expressly waive my right to appeal my sentence, including any appeal right conferred by
Title 18, United States Code, Section 3742 , on any ground other than the following:
- (1) I reserve my right to appeal the district court‘s determination of relevant conduct pursuant to application of guideline section 1B1.3;
- (2) I reserve my right to appeal the total weight of the Ecstasy;
- (3) I reserve my right to appeal any enhancement for an aggravating role under guideline section 3B1.1; and
- (4) I reserve my right to appeal any upward departure from my offense level.
Roche raises three of these reserved issues, arguing that the district judge‘s relevant conduct, drug weight, and aggravating role findings were erroneous. He also contends that the judge erred in two further respects: sentencing him based on facts not found by a jury beyond a reasonable doubt, and declining to award him an acceptance-of-responsibility adjustment under
Reserving the right to appeal some issues does not entitle a defendant to appeal others. See United States v. Whitlow, 287 F.3d 638 (7th Cir. 2002). Roche contends that the right
The judge did err in thinking himself bound by the Guidelines range. Although a generic guilty plea does not preclude a contention that the Guidelines are advisory, Roche has waived such an argument. The parties agreed that Roche‘s sentence would be determined “in accordance with the United States Sentencing Guidelines.” This may be sufficient to trigger the rule that a defendant may not challenge on appeal a punishment to which he agrees. See United States v. Porretta, 116 F.3d 296, 300-01 (7th Cir. 1997); United States v. Nguyen, 46 F.3d 781, 783 (8th Cir. 1995). We need not decide, because Roche has surrendered his right to raise the question in this court. Roche waived the right to appeal “on any ground” other than those specified. The agreement permits Roche to contest the judge‘s factual conclusions but not the application of the Guidelines to the facts as found; fact and law are different “grounds” of decision. Cf. United States v. Grimard-Henry, 399 F.3d 1294 (11th Cir. 2005).
The parties did not foresee Booker, but that does not alter the effect of the plea bargain. The agreement provides that all arguments other than the listed four would be presented to one Article III judge instead of four; to get the substantial benefit offered by the prosecutor, Roche waived the right to challenge his sentence on any other basis, foreseen or not. As we explained in United States v. Bownes, 405 F.3d 634 (7th Cir. 2005), there is nothing special about Booker that precludes enforcement of a waiver. See also
Roche‘s claimed entitlement to the acceptance-of-responsibility adjustment is not worth discussing except to note that his decision to present the argument at all shows that he is unwilling to live by the plea agreement, and hence has not fully accepted responsibility. Making this argument, in the teeth of the agreement‘s unambiguous prohibition, confirms that Roche does not take his obligations seriously.
We turn to the arguments that are proper under the agreement, starting with Roche‘s objection to the relevant-conduct decision. The district judge declined to treat the entire smuggling operation as conduct relevant to the crimes of conviction. Recall that Roche pleaded guilty only to three counts of using a telephone to facilitate a drug transaction. The three sales occurred within four months and involved 235 tablets of ecstasy. The Guidelines provide that the offense level is based on “all reasonably foreseeable acts and omissions of others in furtherance of the jointly undertaken criminal activity, that occurred . . . in preparation for” the offenses of conviction.
None of these findings is clearly erroneous. The conspiracy enlisted Airrion Harvey to ferry ecstasy from Amsterdam to Chicago in the hollow soles of a pair of men‘s boots. (For his trouble, Harvey was paid $5,000 plus expenses for each trip.) Harvey made at least six successful trips; on trip
While recognizing that hearsay is admissible at sentencing, see Williams v. New York, 337 U.S. 241 (1949);
Roche does point out that the pills he sold to Perkins were of a design different from those Harvey brought back from Amsterdam—Perkins purchased pink pills with hearts and purple pills with a 007 stamp, but Harvey claimed to have
Nor is there a problem with the district judge‘s calculation of the total weight of the 24,000 pills. The drug sold as “ecstasy” is typically one of two related compounds, MDA (methylenedioxyamphetamine) or MDMA (3-4 methylenedioxymethamphetamine). Roche dealt in MDMA. Under the 2000 Sentencing Guidelines Manual, which the parties agreed should be used, responsibility for six kilograms of MDMA results in an offense level of 26. Roche argues that the district judge‘s reliance on the 2002 Sentencing Guidelines Manual to estimate the pills’ weight violates the ex post facto clause. It is doubtful that the ex post facto clause plays any role after Booker. United States v. Seacott, 15 F.3d 1380, 1384-86 (7th Cir. 1994), holds that the Guidelines are “laws” for constitutional purposes, but by severing those provisions that made the Guidelines mandatory the Court in Booker demoted the Guidelines from rules to advice. This removes the foundation of Seacott and similar decisions, while leaving in place the requirement that judges use the Guidelines in place at the time of sentencing. See
Roche contends that, instead of the 250 milligram “typical weight per unit” listed in the 2002 Manual for MDA and MDMA, the district judge should have used the 100 milligram weight the 2000 Manual lists for MDA. Yet Roche imported and sold MDMA, not MDA. The 2002 Manual does not change the way MDMA‘s weight is calculated. Moreover, Roche would not get anywhere on this line of argument even if he had distributed MDA. The 2000 Manual itself directs the court not to use the typical-weight table “if any more reliable estimate of the total weight is available from case-specific information.”
A further difficulty is that the 2000 Manual estimated the MDA dosage (the controlled substance) rather than the weight of an MDA pill (the mixture). Yet even under the 2000 Manual, the defendant is responsible for the weight of the whole pill, not just the active ingredient. See
Roche explained that he reserved the right to appeal these factual determinations because he was concerned the district judge would be unable to ignore the bigger picture—Roche‘s involvement in an international drug-smuggling ring—at sentencing. This just shows that Roche‘s challenge to his sentence was risky beyond the repercussions of violating the plea agreement. “[A] defendant who appeals a pre-Booker sentence on the basis that the guidelines were misapplied . . . is playing with fire, because if he wins and is resentenced the judge will have more sentencing latitude, up as well as down, than he did when the guidelines were deemed mandatory.” United States v. Goldberg, 406 F.3d 891, 895 (7th Cir. 2005). The district judge conscientiously attempted to isolate conduct that was “in preparation” for the three particular transactions at issue (which may or may not have been required, see
AFFIRMED
Teste:
Clerk of the United States Court of Appeals for the Seventh Circuit